Prednisolone
About
Therapy type: Chemotherapy
Therapy strategy: Corticosteroid
Mappings
NCI Thesaurus: Prednisolone (ncit:C769)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) HC (1) | BRCA1 oncogenic variants | Prostate Adenocarcinoma | Abiraterone acetate, Olaparib, Prednisolone | |
| FDA (1) HC (1) | BRCA1 pathogenic variants | Prostate Adenocarcinoma | Abiraterone acetate, Olaparib, Prednisolone | |
| FDA (1) HC (1) | BRCA2 oncogenic variants | Prostate Adenocarcinoma | Abiraterone acetate, Olaparib, Prednisolone | |
| FDA (1) HC (1) | BRCA2 pathogenic variants | Prostate Adenocarcinoma | Abiraterone acetate, Olaparib, Prednisolone | |
| FDA (1) | CD20 + | Non-Hodgkin Lymphoma | Cyclophosphamide, Prednisolone, Rituximab, Vincristine | |
| FDA (1) | CD20 + | Non-Hodgkin Lymphoma | Cyclophosphamide, Doxorubicin, Prednisolone, Rituximab, Vincristine | |
| HC (1) | CD20 + | Diffuse Large B-Cell Lymphoma | Cyclophosphamide, Doxorubicin, Prednisolone, Rituximab, Vincristine | |
| HC (1) | CD20 + | Follicular Lymphoma | Cyclophosphamide, Prednisolone, Rituximab, Vincristine |